enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Japan's Otsuka Pharma to pay up to $1.1 billion to acquire ...

    www.aol.com/news/japans-otsuka-pharma-pay-1...

    TOKYO (Reuters) -Japan's Otsuka Pharmaceutical said on Thursday it agreed to pay more than $1 billion to acquire Jnana Therapeutics as it looks to expand its drug pipeline and research base in the ...

  3. Otsuka Pharmaceutical - Wikipedia

    en.wikipedia.org/wiki/Otsuka_Pharmaceutical

    Otsuka Pharmaceutical Co., Ltd. (大塚製薬株式会社, Ōtsuka Seiyaku Kabushiki-gaisha) (TYO: 4578), abbreviated OPC, is a pharmaceutical company headquartered in Tokyo, Osaka and Naruto, Japan. The company was established August 10, 1964.

  4. Astex Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Astex_Pharmaceuticals

    In 2011, Astex Therapeutics Limited and SuperGen, Inc. (US) merged. [10] Following the acquisition, SuperGen, Inc. changed its name to Astex Pharmaceuticals, Inc., and began trading under the ticker symbol ASTX on NASDAQ. [11] The combined Astex entities were subsequently acquired by Otsuka Pharmaceutical in October 2013 for around USD $900 ...

  5. List of largest biomedical companies by market capitalization

    en.wikipedia.org/wiki/List_of_largest_biomedical...

    The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.

  6. TKer: Wall Street strategists nailing one of their more ... - AOL

    www.aol.com/finance/tker-wall-street-strategists...

    Last week, Wall Street began circulating their outlooks for the stock market in 2025. For many folks, the key takeaway from these reports is the year-end price target .

  7. AOL latest headlines, entertainment, sports, articles for business, health and world news.

  8. New Forecasts: Here's What Analysts Think The Future ... - AOL

    www.aol.com/news/forecasts-heres-analysts-think...

    For premium support please call: 800-290-4726 more ways to reach us

  9. Why Summit Therapeutics Skyrocketed 123% This Week - AOL

    www.aol.com/why-summit-therapeutics-skyrocketed...

    Better-than-expected trial data means Summit's bispecific antibody could replace the blockbuster Keytruda as a standard of care for certain lung cancers.